Smith & Nephew SNATS (SNN) Competitors $29.58 +0.25 (+0.84%) Closing price 03:59 PM EasternExtended Trading$29.57 0.00 (-0.02%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, BLCO, NARI, and IRTCShould you be buying Smith & Nephew SNATS stock or one of its competitors? The main competitors of Smith & Nephew SNATS include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry. Smith & Nephew SNATS vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Solventum Penumbra Stevanato Group Glaukos Bausch + Lomb Inari Medical iRhythm Technologies Smith & Nephew SNATS (NYSE:SNN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk. Is SNN or GEHC a better dividend stock? Smith & Nephew SNATS pays an annual dividend of $0.89 per share and has a dividend yield of 3.0%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays out 41.2% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years. Do insiders and institutionals believe in SNN or GEHC? 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, SNN or GEHC? Smith & Nephew SNATS has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Is SNN or GEHC more profitable? GE HealthCare Technologies has a net margin of 11.02% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 24.95% beat Smith & Nephew SNATS's return on equity.Company Net Margins Return on Equity Return on Assets Smith & Nephew SNATSN/A N/A N/A GE HealthCare Technologies 11.02%24.95%6.38% Which has higher earnings and valuation, SNN or GEHC? GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew SNATS$5.81B2.23$412M$2.1613.69GE HealthCare Technologies$19.67B1.76$1.99B$4.7515.88 Do analysts prefer SNN or GEHC? Smith & Nephew SNATS currently has a consensus price target of $28.00, suggesting a potential downside of 5.33%. GE HealthCare Technologies has a consensus price target of $88.55, suggesting a potential upside of 17.36%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew SNATS 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83 Does the media refer more to SNN or GEHC? In the previous week, GE HealthCare Technologies had 11 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 13 mentions for GE HealthCare Technologies and 2 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 1.29 beat Smith & Nephew SNATS's score of 1.07 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 10 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGE HealthCare Technologies beats Smith & Nephew SNATS on 16 of the 19 factors compared between the two stocks. Get Smith & Nephew SNATS News Delivered to You Automatically Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNN vs. The Competition Export to ExcelMetricSmith & Nephew SNATSMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$12.85B$10.23B$5.57B$20.65BDividend Yield3.05%2.09%4.23%3.65%P/E RatioN/A16.9728.6127.29Price / Sales2.2329.08412.3153.17Price / Cash9.2922.6736.0222.28Price / Book2.463.598.234.60Net Income$412M$233.40M$3.23B$995.22M7 Day Performance-3.79%-2.69%-0.01%-0.80%1 Month Performance1.05%1.85%5.61%3.55%1 Year Performance6.65%-18.53%26.52%7.35% Smith & Nephew SNATS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNNSmith & Nephew SNATS2.8855 of 5 stars$29.58+0.8%$28.00-5.3%+5.9%$12.85B$5.81B0.0017,349GEHCGE HealthCare Technologies4.1374 of 5 stars$74.61-1.9%$88.27+18.3%-7.2%$34.83B$19.67B15.7153,000Positive NewsAnalyst ForecastPHGKoninklijke Philips2.9768 of 5 stars$23.84-1.4%N/A-7.3%$23.27B$19.50B55.4466,678ZBHZimmer Biomet4.9506 of 5 stars$92.58-1.2%$111.33+20.3%-11.8%$18.53B$7.68B20.4817,000News CoverageAnalyst UpgradeSOLVSolventum0.7277 of 5 stars$76.24-2.9%$81.50+6.9%+52.8%$13.58B$8.25B14.3822,000Analyst UpgradePENPenumbra4.7411 of 5 stars$248.05-1.2%$302.40+21.9%+23.4%$9.72B$1.19B234.014,500STVNStevanato GroupN/A€24.23-1.5%N/A+21.0%€7.34B€1.19B47.515,521Positive NewsGKOSGlaukos4.3346 of 5 stars$101.69-1.7%$134.67+32.4%-20.2%$5.91B$383.48M-42.91780Analyst ForecastBLCOBausch + Lomb3.0202 of 5 stars$13.83-0.4%$15.54+12.4%-13.4%$4.91B$4.79B-13.4313,500NARIInari Medical0.2605 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800IRTCiRhythm Technologies1.0172 of 5 stars$139.22-2.3%$138.60-0.4%+35.8%$4.55B$591.84M-44.342,000Analyst Forecast Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Zimmer Biomet Competitors Solventum Competitors Penumbra Competitors Stevanato Group Competitors Glaukos Competitors Bausch + Lomb Competitors Inari Medical Competitors iRhythm Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SNN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew SNATS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smith & Nephew SNATS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNN Stock Alerts